These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 18436096)

  • 1. A review of albumin binding in CKD.
    Meijers BK; Bammens B; Verbeke K; Evenepoel P
    Am J Kidney Dis; 2008 May; 51(5):839-50. PubMed ID: 18436096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Albumin turnover: experimental approach and its application in health and renal diseases.
    Prinsen BH; de Sain-van der Velden MG
    Clin Chim Acta; 2004 Sep; 347(1-2):1-14. PubMed ID: 15313137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The binding capacity of albumin and renal disease.
    Dromgoole SH
    J Pharmacol Exp Ther; 1974 Nov; 191(2):318-23. PubMed ID: 4213685
    [No Abstract]   [Full Text] [Related]  

  • 4. Enhanced clearance of highly protein-bound drugs by albumin-supplemented dialysate during modeled continuous hemodialysis.
    Churchwell MD; Pasko DA; Smoyer WE; Mueller BA
    Nephrol Dial Transplant; 2009 Jan; 24(1):231-8. PubMed ID: 18723569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceutical-grade albumin: impaired drug-binding capacity in vitro.
    Olsen H; Andersen A; Nordbø A; Kongsgaard UE; Børmer OP
    BMC Clin Pharmacol; 2004 Mar; 4():4. PubMed ID: 15046641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracorporeal albumin dialysis.
    Abe T; Shono M; Kodama T; Kita Y; Fukagawa M; Akizawa T
    Ther Apher Dial; 2004 Jun; 8(3):217-22. PubMed ID: 15154874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nontraditional risk factors for cardiovascular disease in patients with chronic kidney disease.
    Kendrick J; Chonchol MB
    Nat Clin Pract Nephrol; 2008 Dec; 4(12):672-81. PubMed ID: 18825155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycemic control in diabetic CKD patients: where do we stand?
    Kovesdy CP; Sharma K; Kalantar-Zadeh K
    Am J Kidney Dis; 2008 Oct; 52(4):766-77. PubMed ID: 18572289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sleep disorders occur very early in chronic kidney disease.
    De Santo RM; Bartiromo M; Cesare CM; Cirillo M
    J Nephrol; 2008; 21 Suppl 13():S59-65. PubMed ID: 18446734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of impaired albumin binding capacity in acute-on-chronic liver failure by albumin dialysis.
    Klammt S; Mitzner SR; Stange J; Loock J; Heemann U; Emmrich J; Reisinger EC; Schmidt R
    Liver Transpl; 2008 Sep; 14(9):1333-9. PubMed ID: 18756471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes of serum albumin affinity for aspirin induced by fatty acid.
    Bojko B; Sułkowska A; Maciazek M; Równicka J; Njau F; Sułkowski WW
    Int J Biol Macromol; 2008 May; 42(4):314-23. PubMed ID: 18346781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between dialysate oxidized protein and peritoneal membrane transport properties in patients on peritoneal dialysis.
    Latcha S; Hong S; Gibbons N; Kohn N; Mattana J
    Nephrol Dial Transplant; 2008 Oct; 23(10):3295-301. PubMed ID: 18443211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coated carbon hemoperfusion provides limited clearance of protein-bound solutes.
    Dinh DC; Recht NS; Hostetter TH; Meyer TW
    Artif Organs; 2008 Sep; 32(9):717-24. PubMed ID: 18684207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementing KDOQI CKD definition and staging guidelines in Southern California Kaiser Permanente.
    Rutkowski M; Mann W; Derose S; Selevan D; Pascual N; Diesto J; Crooks P
    Am J Kidney Dis; 2009 Mar; 53(3 Suppl 3):S86-99. PubMed ID: 19231766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Albumin modification and fragmentation in renal disease.
    Donadio C; Tognotti D; Donadio E
    Clin Chim Acta; 2012 Feb; 413(3-4):391-5. PubMed ID: 22120732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Out-of-office blood pressure monitoring in chronic kidney disease.
    Agarwal R; Peixoto AJ; Santos SF; Zoccali C
    Blood Press Monit; 2009 Feb; 14(1):2-11. PubMed ID: 19194283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
    Alcázar Arroyo R
    Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statin treatment for dyslipidemia in chronic kidney disease and renal transplantation: a review of the evidence.
    Kanbay M; Turgut F; Covic A; Goldsmith D
    J Nephrol; 2009; 22(5):598-609. PubMed ID: 19809992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.